Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-24 @ 2:31 PM
NCT ID:
NCT03788759
Eligibility Criteria:
Inclusion Criteria:
* Capacity to provide informed consent;
* Schizophrenia diagnosis (made by research psychiatrists using the Structured Clinical Interview, SCID-5, for Diagnostic and Statistical Manual of Mental Disorders);
* Negative and/or cognitive symptoms despite adequate antipsychotic treatment;
* Ages 18-60 years
Exclusion Criteria:
* 6-month history of any drug or alcohol abuse or dependence;
* Changes in psychotropic medications within the last 4 weeks;
* Actual valproate use (potential interaction with ALA);
* General medical illness including autoimmune disorders, known chronic infections such as HIV or hepatitis C, and liver or renal failure that could adversely impact on patient outcome;
* Women who are planning to become pregnant, are pregnant, or are breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT03788759
Study Brief:
Protocol Section:
NCT03788759